The Pyruvate Dehydrogenase Complex (PDC) plays a critical role in the regulation of carbohydrate metabolism. Pyruvate Dehydrogenase Kinase (PDK) inhibits PDC via phosphorylation making it a novel therapeutic target for metabolic diseases. The present study aimed to evaluate whether the metabolism of HP-13C pyruvate is sensitive to PDK inhibition. Our results showed that higher production of HP-bicarbonate via PDC in PDK deficient livers. 13C NMR isotopomer analysis of tissue extracts confirms higher 13C-enrichment of
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords